Phio Pharmaceuticals (PHIO) vs Vistagen Therapeutics (VTGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Phio Pharmaceuticals (PHIO) has outperformed Vistagen Therapeutics (VTGN) over the past year, losing 57.5% versus a loss of 93.8%. Over five years, PHIO leads with a -99.4% price change compared with -99.7% for VTGN. Phio Pharmaceuticals is the larger company by market cap ($11.6 million vs $11.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PHIO | VTGN |
|---|---|---|
| Share price | $0.9995 | $0.2471 |
| Market cap | $11.61M | $10.97M |
| 1-day change | +0.51% | -1.40% |
| YTD return | -4.81% | -62.56% |
| 1-year return | -57.47% | -93.76% |
| 5-year return | -99.45% | -99.66% |
| EPS (TTM) | $-1.28 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $5.14 |
| 52-week low | $0.813 | $0.20 |
| Distance from 52-week high | -76.15% | -95.19% |
| Average volume | 591.85K | 12.40M |
| Shares outstanding | 11.62M | 44.38M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PHIO has outperformed VTGN by 36.3 percentage points over the past year.
PHIO vs VTGN FAQ
Which is bigger, Phio Pharmaceuticals or Vistagen Therapeutics?
Phio Pharmaceuticals (PHIO) is larger, with a market capitalization of $11.61M compared with $10.97M for Vistagen Therapeutics (VTGN).
Which stock has performed better over the past year, PHIO or VTGN?
PHIO returned -57.47% over the past 12 months, compared with -93.76% for VTGN (price return, excluding dividends). Past performance does not predict future results.
Are Phio Pharmaceuticals and Vistagen Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.